Biotransformation of the immunomodulator, 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazolo[3,2a]benzimidazole-2-acetic acid, and its relationship to tyroid toxicity
- 1 June 1981
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 59 (2) , 355-363
- https://doi.org/10.1016/0041-008x(81)90207-6
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Immunomodulating and Antimetastatic Activity of 3–(P-Chlorophenyl) Thiazolo[3, 2-A]Benzimidazole-2-Acetic Acid (Wy-18, 251, Nsc 310633)Journal of Immunopharmacology, 1980
- The immunostimulatory activity of 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazole [3, 2-α]-benzimidazole-2-acetic acid (NSC 208828)Published by Elsevier ,1978
- METABOLISM OF SUDOXICAM BY RAT, DOG, AND MONKEY1977
- Syntheses of heterocyclic fused thiazole acetic acids. 2Journal of Medicinal Chemistry, 1976
- The Mechanism of Action of the Thioureylene Antithyroid DrugsEndocrinology, 1976
- Anti-tumour and anti-metastatic activity of 3-(P-Chlorophenyl)-2,3-Dihydro-3-Hydroxythiazolo [3,2-a]-Benzimidazole-2-acetic acid (WY-13,876)British Journal of Cancer, 1976
- Hepatic and extrahepatic metabolism of the psychotropic drugs, chlorpromazine, imipramine, and imipramine-N-oxideNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1971
- Antithyroid substances. 1. The mercaptoglyoxalinesBiochemical Journal, 1950